Pennsylvania HB 321: An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; and establishing the Pharmaceutical Transparency Review Fund.

Status: PN 0295 Referred to INSURANCE (as of 2021-01-28)

State: Pennsylvania · Session: 2021-2022 · Bill: HB 321

Sponsors: Puskaric, Bernstine, Boback, Ciresi, Gleim, Hamm, Hershey, Moul, Mullins, Struzzi

View Pennsylvania HB 321 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.